SIM
FLXN

Spark Investment Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Spark Investment Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-71,632
Closed -$563K – 341
2020
Q1 		$563K Sell
71,632
-30,791
-30% -$464K 0.3% 114
2019
Q4 		$2.12M Sell
102,423
-14,877
-13% -$251K 0.25% 130
2019
Q3 		$1.61M Hold
117,300
– – 0.21% 130
2019
Q2 		$1.44M Buy
117,300
+498
+0.4% +$5.75K 0.1% 248
2019
Q1 		$1.46M Buy
+116,802
New +$1.56M 0.07% 294
2015
Q2 		– Sell
-24,600
Closed -$553K – 770
2015
Q1 		$553K Buy
+24,600
New +$570K 0.08% 352
2014
Q3 		– Sell
-10,200
Closed -$136K – 747
2014
Q2 		$136K Buy
10,200
+100
+1% +$1.36K 0.02% 536
2014
Q1 		$166K Buy
+10,100
New +$175K 0.03% 557

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Spark Investment Management's FLXN Position: Q2 2020 in Review

Spark Investment Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2020, closing a stake of 71,632 shares — an estimated $563K sold.

Spark Investment Management first reported a position in FLXN in Q1 2014 and held it in 8 quarters. The position peaked at $2.12M in Q4 2019. 125 funds tracked by Wall St. Rank hold FLXN as of Q2 2020.

  • Spark Investment Management reported no remaining Flexion Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 71,632 Flexion Therapeutics, Inc. shares in Q2 2020, an estimated $563K.
  • Spark Investment Management first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and held it in 8 quarters.
  • Spark Investment Management's Flexion Therapeutics, Inc. position peaked at $2.12M in Q4 2019.
  • 125 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.